Grace Therapeutics, Inc.
GRCE
$2.72
-$0.08-2.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -55.98% | -43.83% | -10.34% | -17.52% | -19.65% |
| Total Receivables | -68.61% | -50.42% | -52.45% | -9.98% | 23.26% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.11% | -54.31% | -44.81% | -52.68% | -22.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -55.59% | -44.40% | -13.48% | -18.03% | -19.58% |
|
|
|||||
| Total Current Assets | -55.59% | -44.40% | -13.48% | -18.03% | -19.58% |
| Net Property, Plant & Equipment | -45.71% | -63.16% | -85.16% | -99.12% | -94.16% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -37.23% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -37.23% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.05% | -41.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -19.64% | -16.44% | -4.54% | -7.36% | -34.77% |
|
|
|||||
| Total Accounts Payable | -27.16% | 144.53% | 155.19% | -18.92% | -72.83% |
| Total Accrued Expenses | 56.78% | 50.00% | -17.83% | -67.67% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -67.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.36% | 91.41% | 32.25% | -50.63% | -48.44% |
|
|
|||||
| Total Current Liabilities | 11.36% | 91.41% | 32.25% | -50.63% | -48.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.92% | -35.03% | 9.88% | 34.38% | -39.97% |
| Total Liabilities | -21.03% | -19.62% | 14.75% | 3.48% | -42.71% |
|
|
|||||
| Common Stock & APIC | 0.30% | 0.36% | 2.50% | 2.44% | 2.48% |
| Retained Earnings | -6.43% | -5.65% | -5.66% | -6.48% | -22.92% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -19.39% | -15.90% | -7.26% | -9.14% | -33.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.39% | -15.90% | -7.26% | -9.14% | -33.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.39% | -15.90% | -7.26% | -9.14% | -33.13% |
|
|
|||||